Cargando…
Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study
OBJECTIVE: To determine if variations in trial eligibility criteria and patient baseline characteristics could be considered effect modifiers of the treatment response when testing targeted therapies (biological agents and targeted synthetic disease modifying antirheumatic drugs (DMARDs)) for rheuma...
Autores principales: | Christensen, Anton Wulf, Tarp, Simon, Furst, Daniel E., Døssing, Anna, Amris, Kirstine, Bliddal, Henning, Taylor, Peter C., Christensen, Robin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567072/ https://www.ncbi.nlm.nih.gov/pubmed/26360583 http://dx.doi.org/10.1371/journal.pone.0136982 |
Ejemplares similares
-
Can the painDETECT Questionnaire score and MRI help predict treatment outcome in rheumatoid arthritis: protocol for the Frederiksberg hospital's Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study
por: Rifbjerg-Madsen, Signe, et al.
Publicado: (2014) -
The course of pain hypersensitivity according to painDETECT in patients with rheumatoid arthritis initiating treatment: results from the prospective FRAME-cohort study
por: Rifbjerg-Madsen, Signe, et al.
Publicado: (2018) -
Temporal summation of pain and ultrasound Doppler activity as predictors of treatment response in patients with rheumatoid arthritis: protocol for the Frederiksberg hospitals Rheumatoid Arthritis, pain assessment and Medical Evaluation (FRAME-cohort) study
por: Christensen, Anton Wulf, et al.
Publicado: (2014) -
Interpreting trial results following use of different intention-to-treat approaches for preventing attrition bias: a meta-epidemiological study protocol
por: Dossing, Anna, et al.
Publicado: (2014) -
Agreements and Discrepancies between FDA Reports and Journal Papers on Biologic Agents Approved for Rheumatoid Arthritis: A Meta-Research Project
por: Amarilyo, Gil, et al.
Publicado: (2016)